Narcotic drugs could soon be manufactured by yeast
Synthetic biology—the technique of moving genes from creature to creature not one at a time, but by the handful—promises much but has yet to deliver. Someone who believes it can, though, is Christina Smolke of Stanford University. And, as she and her colleagues write in Nature Chemical Biology, they think they now know one way that it might.
Opiates, such as morphine, are widely used as painkillers. Some are extracted directly from opium poppies (paler, as the picture shows, than the sort familiar in Europe and North America), which grow well in places such as Afghanistan and Turkey. Others, such as oxycodone, are chemically derived from natural poppy-molecules. Many of these drugs, though, are also used for recreational purposes—particularly diamorphine, an acetylated version of the principal poppy extract that was branded “Heroin” by its manufacturer, Bayer, in the late 19th century. Since such recreational use is generally illegal, the authorities keep a strict eye on the opium trade, and would no doubt welcome the chance to make that eye even stricter by cutting poppies out of the loop and making diamorphine and its cousins from scratch in facilities they can watch. That, plus the possibility the drugs might be produced more cheaply, has encouraged Dr Smolke to use synthetic biology to see if she can create an alternative source for opiates.
To do so, her team added three crucial poppy genes to some yeast cells. When provided with the appropriate chemical precursor, the modified yeast cranked out morphine and another opiate, codeine. And when one of the poppy genes was itself replaced by two genes from Pseudomonas putida, a soil bacterium, the yeast made oxycodone and hydrocodone too. Though this prototype yeast was not particularly efficient, some further tweaking converted it into a veritable drug factory—capable of cooking up 131mg of opioids (the equivalent of about 26 medical doses of diamorphine) per litre of culture over a four-day manufacturing cycle.
The Latest on: Synthetic biology
[google_news title=”” keyword=”Synthetic biology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Synthetic biology
- Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)on May 2, 2024 at 5:00 am
Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office has allowed patent application 17/232,393, titled “Halogenated Xanthene Composition ...
- Programmable Living Materials Created Using Synthetic Biology and 3D Printingon May 2, 2024 at 2:07 am
Scientists are harnessing cells to make new materials that can grow, repair themselves and even respond to their environment.
- Shiru harnesses AI to launch protein discovery platform: ‘It’s like Amazon for proteins…’on May 1, 2024 at 8:17 am
Shiru is launching a first-of-its-kind discovery platform and marketplace for proteins, enabling companies to identify and test proteins.
- Marriage of synthetic biology and 3D printing produces programmable living materialson May 1, 2024 at 6:42 am
Scientists are harnessing cells to make new types of materials that can grow, repair themselves and even respond to their environment. These solid "engineered living materials" are made by embedding ...
- Engineered living materials: Scientists 3D print with bio-ink made from tobacco cellson May 1, 2024 at 5:03 am
Also known as EPLMs, “engineered plant living materials” are a new frontier that marries synthetic biology and 3D printing, an invention that’s inspired many improvements to the mechanism itself as ...
- Crafting Programmable Living Materials With Synthetic Biology & 3D Printingon May 1, 2024 at 4:59 am
New study uses 3D printing and genetically modified plant cells to create complex, self-repairing materials that could revolutionize biomanufacturing and construction. Scientists are harnessing cells ...
- Vaccine Developers Leverage mRNA and Other Powerful Technologieson April 30, 2024 at 5:00 pm
Grint is entrepreneur in residence at the University of California, San Diego, and holds board-level positions in several companies, including Codagenix, which combines live, attenuated virus design ...
- BioP2P’s Matt Gardner to Speak at SynBioBeta Global Synthetic Biology Conferenceon April 30, 2024 at 9:03 am
Matt Gardner, Board President of the California Biomanufacturing Center and Chair of the BioProcess to Product Network (BioP2P), is scheduled to speak at the 2024 SynBioBeta Global Biology Conference.
- Ansa Biotechnologies to Showcase Early Access Customer Success at Upcoming Global Synthetic Biology Conferenceon April 30, 2024 at 5:03 am
Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced its speaker lineup for presentations at the upcoming Global Synthetic Biology (SynBioBeta) Conference in San ...
- Synthetic droplets cause a stir in the primordial soup: Chemotaxis research answers questions about biological movementon April 25, 2024 at 7:14 am
Simple yet profound questions like these are at the heart of curiosity-driven basic research, which focuses on the fundamental principles of natural phenomena. An important example is the process by ...
via Bing News